Atea

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atea and other ETFs, options, and stocks.

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.

CEO

Jean-Pierre Sommadossi

CEOJean-Pierre Sommadossi

Employees

Employees56

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2012

Founded2012

Employees

Employees56

AVIR Key Statistics

Market cap

245.03M

Market cap245.03M

Price-Earnings ratio

-1.44

Price-Earnings ratio-1.44

Dividend yield

—

Dividend yield—

Average volume

530.04K

Average volume530.04K

High today

$2.88

High today$2.88

Low today

$2.79

Low today$2.79

Open price

$2.88

Open price$2.88

Volume

573.08K

Volume573.08K

52 Week high

$4.15

52 Week high$4.15

52 Week low

$2.60

52 Week low$2.60

Atea

Why Robinhood?

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. Show more

AVIR Key Statistics

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.